Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Large Growth in Short Interest

Autonomix Medical, Inc. (NASDAQ:AMIX) saw a significant increase in short interest in the month of July. As of July 31st, there was short interest totaling 263,441 shares, an increase of 327.2% from the July 15th total of 61,662 shares. Currently, 28.9% of the company’s shares are short sold. Based on an average daily volume of 7,539,029 shares, the short-interest ratio is presently 0.0 days.

Autonomix Medical Stock Performance

Shares of AMIX stock opened at $9.12 on Wednesday. Autonomix Medical has a fifty-two week low of $2.44 and a fifty-two week high of $32.55. The stock has a 50 day simple moving average of $6.87 and a two-hundred day simple moving average of $7.78. The company has a market cap of $8.86 million, a P/E ratio of -0.12 and a beta of -1.16.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on the stock. Weiss Ratings raised shares of Autonomix Medical from a “sell (e)” rating to a “sell (e+)” rating in a research note on Tuesday, July 28th. Zacks Research raised Autonomix Medical to a “hold” rating in a report on Tuesday, June 2nd. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $42.00.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.